Nearly the next anti-David vaccine, ten times cheaper than Pfizer

Oxford University Leader supported by AstraZeneca, Professor Andrew Pollard, says the team is oppositive about taking the vaccine by Christmas.

The academy says their anti-viral will be, ten times cheaper than Pfizer's product, which requires two injections of several weeks away and must be preserved in -78C.

“We have been working without recall throughout the year and we look forward to seeing the results in the following months. We're a small academic team at Oxford. It is a miracle that we have been able to perform evidence of a large scale at such a record time. Our partner AstraZeneca will hand over the vaccine on a non-profit basis”, he said, among other things.

He told The Sun '%s' that their vaccine is stored in the refrigerator's camera and it's very close to demonstrating the integrity of something Pfizer tried in her version on Monday.